Lucy Meunier

1.6k total citations
44 papers, 546 citations indexed

About

Lucy Meunier is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Lucy Meunier has authored 44 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Lucy Meunier's work include Drug-Induced Hepatotoxicity and Protection (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver Disease and Transplantation (7 papers). Lucy Meunier is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver Disease and Transplantation (7 papers). Lucy Meunier collaborates with scholars based in France, Belgium and Netherlands. Lucy Meunier's co-authors include Dominique Larrey, Georges‐Philippe Pageaux, Magdalena Meszaros, Josè Ursic‐Bedoya, Stéphanie Faure, J. Meynadier, Nadia Raison‐Peyron, Bénédicte Delire, Eléonora De Martin and Ismaël Conejero and has published in prestigious journals such as Nature Communications, Applied and Environmental Microbiology and International Journal of Molecular Sciences.

In The Last Decade

Lucy Meunier

35 papers receiving 535 citations

Peers

Lucy Meunier

ONCOL

EPIDE

PHARM

HEPAT

Pavitra Keshavan United States

Yoon Hwan Chang South Korea

E. Musch Germany

Sylvia Stella Amaral Brazil

Fang Xiao China

Ling Mei China

G.C. Naccari Italy

Shixue Dai China

Chi-Hung Cheng Taiwan

Miriam Ruth Bueno‐Topete Mexico

Pavitra Keshavan United States

Lucy Meunier

77 ×0.6

ONCOL

186 ×1.5

EPIDE

254 ×2.2

64 ×0.6

PHARM

37 ×0.4

HEPAT

Citations per year, relative to Lucy Meunier Lucy Meunier (= 1×) peers Pavitra Keshavan

Countries citing papers authored by Lucy Meunier

Since Specialization

Citations

This map shows the geographic impact of Lucy Meunier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Meunier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Meunier more than expected).

Fields of papers citing papers by Lucy Meunier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Meunier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Meunier. The network helps show where Lucy Meunier may publish in the future.

Co-authorship network of co-authors of Lucy Meunier

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Meunier. A scholar is included among the top collaborators of Lucy Meunier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Meunier. Lucy Meunier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ursic‐Bedoya, Josè, Astrid Herrero, Stéphanie Faure, et al.. (2025). Disparities in transplant access and outcomes after first cirrhosis decompensation in alcohol-related liver disease. JHEP Reports. 7(12). 101594–101594.

Faure, Stéphanie, et al.. (2025). Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury. Liver International. 45(5). e70073–e70073.

Faure, Stéphanie, Marie Dupuy, Dominique Larrey, et al.. (2024). Time to use the right classification to predict the severity of checkpoint inhibitor‐induced liver injury, as assessed for causality using the updated RUCAM. Alimentary Pharmacology & Therapeutics. 60(11-12). 1561–1572. 6 indexed citations

Meunier, Lucy, Eléonora De Martin, Bénédicte Delire, et al.. (2024). CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatment. JHEP Reports. 6(7). 101098–101098. 9 indexed citations

Larrey, Dominique, et al.. (2024). Drug‐induced liver injury related to gene therapy: A new challenge to be managed. Liver International. 44(12). 3121–3137. 4 indexed citations

Renault, Thomas, et al.. (2023). Acute liver failure following immune checkpoint inhibitors. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102203–102203. 9 indexed citations

Lebossé, Fanny, Xavier Quantin, C. Lesage, et al.. (2023). Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort. JHEP Reports. 5(6). 100719–100719. 43 indexed citations

Meunier, Lucy, et al.. (2023). Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data. Clinical Gastroenterology and Hepatology. 22(7). 1542–1545.e4. 12 indexed citations

Maria, A., et al.. (2023). Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102192–102192. 1 indexed citations

10.

Dumortier, Jérôme, Arnaud Del Bello, Lucie Gamon, et al.. (2023). Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse. JHEP Reports. 5(10). 100832–100832. 11 indexed citations

11.

Meunier, Lucy & Dominique Larrey. (2023). Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility. International Journal of Molecular Sciences. 24(1). 852–852. 7 indexed citations

12.

Meunier, Lucy, et al.. (2022). Mycophenolate mofetil discontinuation increases severe acute respiratory syndrome coronavirus 2 vaccine response in nonresponder liver transplantation recipients: A proof of concept. Liver Transplantation. 29(1). 114–117. 5 indexed citations

13.

Meunier, Lucy, Jérôme Dumortier, Magdalena Meszaros, et al.. (2022). Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients. Liver International. 42(8). 1872–1878. 16 indexed citations

14.

Meunier, Lucy, et al.. (2021). Hydrochlorothiazide-induced hepatotoxicity: A rare case of DILI. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101599–101599.

15.

Quantin, Xavier, Jean‐Luc Faillie, C. Lesage, et al.. (2021). Gestion des toxicités induites par les inhibiteurs de checkpoint immunologique : données de la réunion de concertation pluridisciplinaire « ToxImmun » en Occitanie Est. La Revue de Médecine Interne. 42(5). 310–319. 4 indexed citations

16.

Ursic‐Bedoya, Josè, Jérôme Dumortier, Romain Altwegg, et al.. (2020). Alcohol Consumption the Day of Liver Transplantation for Alcohol‐Associated Liver Disease Does Not Affect Long‐Term Survival: A Case‐Control Study. Liver Transplantation. 27(1). 34–42. 8 indexed citations

17.

Meunier, Lucy & Dominique Larrey. (2020). Chemotherapy-associated steatohepatitis. Annals of Hepatology. 19(6). 597–601. 52 indexed citations

18.

Meunier, Lucy, Josè Ursic‐Bedoya, Georges‐Philippe Pageaux, & Dominique Larrey. (2018). Pantoprazole‐induced autoimmune chronic hepatitis. Liver International. 38(6). 995–999. 5 indexed citations

19.

Meunier, Lucy & Dominique Larrey. (2018). Recent Advances in Hepatotoxicity of Non Steroidal Anti-inflammatory Drugs. Annals of Hepatology. 17(2). 187–191. 35 indexed citations

20.

Ligeron, C, et al.. (2001). Erythrocyanose réticulée hémicorporelle. Annales de Dermatologie et de Vénéréologie. 128. 925–926.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact